Keytruda's New Tissue-Agnostic Indication Could Prompt Orphan Policy Changes

 
• By Derrick Gingery
  
FDA commissioner Scott Gottlieb
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet